<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04823481</url>
  </required_header>
  <id_info>
    <org_study_id>CE_20210126_8_PSS</org_study_id>
    <nct_id>NCT04823481</nct_id>
  </id_info>
  <brief_title>Acute Anterior or Posterior Cerebral Artery Occlusion Recanalization Therapy and Relationships With Clinical Outcome (ACAPULCO)</brief_title>
  <acronym>ACAPULCO</acronym>
  <official_title>Acute Anterior or Posterior Cerebral Artery Occlusion Recanalization Therapy and Relationships With Clinical Outcome (ACAPULCO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nearly 3% of patients with ischaemic stroke (IS) have an isolated occlusion of the anterior&#xD;
      or posterior cerebral artery in the acute phase of the disease. In those patients,&#xD;
      intravenous thrombolysis (IT) is indicated for 4.5 hours after symptoms onset. Due to a lack&#xD;
      of data, mechanical thrombectomy (MT) is not considered as a gold standard to treat IS alone&#xD;
      or in addition with IT. Therefore, observational studies are needed to understand the&#xD;
      clinical evolution of patients with IS treated with IT and/or MT. The ACAPULCO retrospective&#xD;
      observational study aims to highlight potential benefits of MT in those patients to improve&#xD;
      their management and to propose targeted therapies in the future.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinico-radiological evolution of IS patients with isolated occlusion of the anterior or posterior cerebral artery.</measure>
    <time_frame>90 days</time_frame>
    <description>Good Neurological Condition Good neurological outcome (GNO) at 3 months will defined using the modified Rankin Scale (mRS). A normal/near normal outcome after procedure is associated with a mRS Scale score = 0-1 and severe disability/death is associated with a mRS Scale score = 5-6</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Ischemic Stroke</condition>
  <condition>Thrombi</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects having clinical signs and imaging criteria consistent with acute ischemic stroke&#xD;
        who presented within 6 hours of stroke symptoms onset with isolated occlusion of the&#xD;
        anterior or the posterior artery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 and &lt; 96&#xD;
&#xD;
          -  Clinical signs consistent with acute ischemic stroke&#xD;
&#xD;
          -  Patients who presented within 6 hours of stroke symptoms onset&#xD;
&#xD;
          -  Isolated occlusion of the anterior or the posterior artery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Administration of recanalization treatment before hospital admission&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Seners, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Fondation Adolphe de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Seners, MD, PhD</last_name>
    <phone>(0)148037859</phone>
    <email>pseners@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amélie Yavchitz, MD,PhD</last_name>
    <phone>+33148036454</phone>
    <email>ayavchitz@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Fondation Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <state>Ile-de-France</state>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Candice Sabben, MD, PhD</last_name>
      <phone>+33148036538</phone>
      <email>csabben@for.paris</email>
    </contact>
    <contact_backup>
      <last_name>Amélie Yavchitz, MD, PhD</last_name>
      <phone>(0)148036454</phone>
      <email>ayavchitz@for.paris</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 26, 2021</study_first_submitted>
  <study_first_submitted_qc>March 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2021</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemic Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

